Skip to main content

Table 4 Known-Group Validity of the MDASI-COVID

From: Measuring symptom burden in patients with cancer during a pandemic: the MD Anderson symptom inventory for COVID-19 (MDASI-COVID)

MDASI-COVID subscale

Hospital status

n

Mean

SD

Mean difference

LCL of the diff

95%

UCL of the diff 95%

P

Cohen’s d

Core

Not hospitalized

522

1.81

1.95

–0.79

–1.27

-0.31

0.001*

0.40

Hospitalized

75

2.61

2.12

     

Module (11 items)

Not hospitalized

522

1.66

2.02

–0.48

–0.97

0.02

0.06

0.23

Hospitalized

75

2.14

2.24

     

Module (14 items)

Not hospitalized

522

1.59

1.92

–0.52

–0.99

–0.04

0.03*

0.26

Hospitalized

75

2.111

2.19

     

All symptom items (24 items)

Not hospitalized

523

1.74

1.90

–0.65

–1.12

–0.18

0.007*

0.33

Hospitalized

75

2.39

2.11

     

All symptom items (27 items)

Not hospitalized

523

1.70

1.86

–0.66

–1.12

–0.20

0.005*

0.35

Hospitalized

75

2.36

2.08

     

Interference

Not hospitalized

522

2.22

2.66

–1.10

–1.76

–0.33

0.001*

0.41

Hospitalized

75

3.31

3.01

     

WAW

Not hospitalized

522

2.35

2.93

–1.39

–2.11

–0.67

< 0.001*

0.47

Hospitalized

75

3.74

3.28

     

REM

Not hospitalized

522

2.08

2.63

–0.79

–1.44

-0.14

0.02*

0.30

Hospitalized

75

2.87

2.98

     
  1. * Significant at P < .05
  2. Abbreviations: COVID, novel coronavirus disease 2019; LCL, lower 95% confidence limit; MDASI, MD Anderson Symptom Inventory; REM, composite of the interference items relations with other people, enjoyment of life, and mood; UCL, upper 95% confidence limit; WAW, composite of the interference items work, general activity, and walking